相关实验视频
Updated: May 13, 2025

07:06
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
32.7K
奎蒂亚平和儿科精神病学:证据还是差异?
Ahmed Naguy1, Saxby Pridmore2, Hend Fm Fr Alenezi3
1Naguy, MBBch, MSc, MRCPsych (UK), Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Shuwaikh, State of Kuwait.
Psychopharmacology bulletin
|April 14, 2025
概括
奎蒂亚平是一种非典型的抗精神病药物,已被FDA批准用于儿童发作精神分裂症和青少年双相情感障碍. 本综述审查了其临床用途和支持儿童和青少年精神病学方面的证据.
科学领域:
- 儿童和青少年精神病学
- 药理学 药理学是指药理学的学科.
- 临床治疗学 临床治疗学
背景情况:
- 奎蒂亚平是一种非典型的抗精神病药物,在市场上已有确定的存在.
- 它已获得FDA的批准,用于特定的儿科精神健康状况.
研究的目的:
- 审查在儿童和青少年精神病学中已确立的奎蒂亚平的临床适用性.
- 检查现有的证据支持其在这个人群中的治疗用途.
主要方法:
- 专注的文献审查.
- 检查现有的临床证据.
主要成果:
- 奎蒂亚平已被批准用于儿童发作的精神分裂症.
- 奎蒂亚平已被批准用于青少年双相情绪障碍.
- 它的药理学特征表明它具有广泛的精神药物潜力.
结论:
- 奎蒂亚平是一种多功能药物,在儿科心理健康中发挥着既定的作用.
- 进一步检查证据支持其临床应用.
相关概念视频
Psychosis: Goals of Pharmacotherapy
96
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
96
Mania and Antimanic Drugs: Overview
103
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
103
Antipsychotic Drugs: Typical and Atypical Agents
123
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
123
Sedatives and Hypnotics Drugs: Miscellaneous Agents
129
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
129
Antiepileptic Drugs: GABAergic Pathway Potentiators
261
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
261
Antiepileptic Drugs: Potassium Channel Activators
127
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
127

